
CAS 1945950-21-9
:Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
1-[(1,3-Dimethyl-1H-pyrazol-5-yl)methyl]-1,2,3,4-tetrahydro-N-(1-methylcyclopropyl)-3-[(2-methyl-5-thiazolyl)methyl]-2,4-dioxo-6-quinazolinesulfonamide
CAS:Formula:C23H26N6O4S2Purity:98%Color and Shape:SolidMolecular weight:514.6203Ref: IN-DA01ENKB
1mg186.00€5mg246.00€10mg545.00€25mg639.00€50mgTo inquire100mgTo inquire200mgTo inquirePARG Inhibitor PDD00017273
CAS:Formula:C23H26N6O4S2Purity:≥ 98.0%Color and Shape:White to yellow or beige powderMolecular weight:514.62PDD00017273
CAS:<p>PDD00017273 is a radiosensitizing PARG) inhibitor with antitumor or activity for the study of epithelial ovaries.</p>Formula:C23H26N6O4S2Purity:99.14% - 99.21%Color and Shape:SolidMolecular weight:514.621-[(1,3-Dimethyl-1H-pyrazol-5-yl)methyl]-1,2,3,4-tetrahydro-N-(1-methylcyclopropyl)-3-[(2-methyl-5-thiazolyl)methyl]-2,4-dioxo-6-quinazolinesulfonamide
CAS:Purity:95%Molecular weight:514.6199951PDD 00017273
CAS:<p>PDD 00017273 is a monoclonal antibody that targets the adenosine diphosphate-ribose (ADP-ribose) termini of cancer cells. It binds to the ADP-ribose termini and prevents them from being labeled with monomers, which are necessary for DNA synthesis. PDD 00017273 has been shown to specifically bind to human cancers, including breast, prostate, lung, colorectal, leukemia, and lymphoma. The drug has been shown to produce tumor shrinkage in animal models and is currently in clinical trials for treatment of human cancers. 1) 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is an anti-tuberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding</p>Formula:C23H26N6O4S2Purity:Min. 95%Molecular weight:514.62 g/mol






